IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 158 filers reported holding IMMUNOGEN INC in Q4 2016. The put-call ratio across all filers is 5.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $206,000 | -22.3% | 101,201 | +2.5% | 0.00% | – |
| Q3 2016 | $265,000 | -14.0% | 98,757 | -1.3% | 0.00% | – |
| Q2 2016 | $308,000 | -47.4% | 100,024 | +45.5% | 0.00% | -100.0% |
| Q1 2016 | $586,000 | -34.5% | 68,729 | +4.2% | 0.00% | 0.0% |
| Q4 2015 | $895,000 | -3.5% | 65,929 | -31.7% | 0.00% | 0.0% |
| Q3 2015 | $927,000 | -34.5% | 96,542 | -1.9% | 0.00% | 0.0% |
| Q2 2015 | $1,415,000 | +185.3% | 98,383 | +77.7% | 0.00% | 0.0% |
| Q1 2015 | $496,000 | +71.6% | 55,367 | +17.0% | 0.00% | – |
| Q4 2014 | $289,000 | -45.0% | 47,312 | -4.5% | 0.00% | -100.0% |
| Q3 2014 | $525,000 | -13.5% | 49,560 | -3.2% | 0.00% | 0.0% |
| Q2 2014 | $607,000 | -42.8% | 51,182 | -28.1% | 0.00% | 0.0% |
| Q1 2014 | $1,062,000 | +31.4% | 71,141 | +29.2% | 0.00% | 0.0% |
| Q4 2013 | $808,000 | -7.1% | 55,079 | +7.7% | 0.00% | 0.0% |
| Q3 2013 | $870,000 | +2.7% | 51,119 | +0.1% | 0.00% | 0.0% |
| Q2 2013 | $847,000 | – | 51,081 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |